Navega Therapeutics Gets CIRM Grant for Chronic Pain Treatment
Next-generation AAV gene therapy targets intractable chronic pain Navega Therapeutics, a biotechnology company developing epigenetic gene therapies, today announced the receipt of a $4M Translational Science grant...